CAR-T cells targeting CD19

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

CAR-T cells targeting CD19
Treatment and conditionWhere it standsTrials
CAR-T cells targeting CD19 for scleroderma, systemicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1